Non-alcoholic steatohepatitis Trials in Richmond, United States
Conditions / Non-alcoholic steatohepatitis / Richmond, United States
Non-alcoholic steatohepatitis has been the subject of sustained clinical investigation across multiple research sites.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04822181 | Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) | ACTIVE_NOT_RECRUITING | — |
| NCT02970942 | Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis. | COMPLETED | PHASE2 |
| NCT00678587 | Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures | TERMINATED | PHASE3 |
| NCT02686762 | Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis | COMPLETED | PHASE2 |
| NCT04822181 | Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) | ACTIVE_NOT_RECRUITING | — |
| NCT05016882 | Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH) | COMPLETED | PHASE2 |
| NCT02960204 | Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension | COMPLETED | PHASE2 |
| NCT04171765 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis | TERMINATED | PHASE2 |
| NCT02787304 | Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH) | TERMINATED | PHASE2 |
| NCT04822181 | Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) | ACTIVE_NOT_RECRUITING | — |